Home
Octagon Capital Advisors reported a 6.4% stake in Palisade Bio PALI · 9,567,898 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 6.4%
- Last report
- First report
- Shares held
- 9,567,898 sh
- Class
- Common Stock, $0.01 par value
- Stock
- Palisade Bio PALI
- Holder
- Octagon Capital Advisors
- Event date
- 25/12/31
- Filed
- 26/02/10
First 5%+ report · 6.4% stake
Palisade Bio trades, last 26 weeks
What else happened in Palisade Bio around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Octagon Capital Advisors's other 5% stake reports
- Octagon Capital Advisors
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
3.3% stake
3,050,000 sh
3.3% stake
Filed 07/31
- Octagon Capital Advisors
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
5.7% stake
5,250,000 sh
5.7% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeCorbus Pharmaceuticals Holdings
5% stakeCorbus Pharmaceuticals Holdings
CRBP
0% stake
0 sh
0% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeGossamer Bio
5% stakeGossamer Bio
GOSS
3.8% stake
8,976,054 sh
3.8% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeDianthus Therapeutics
5% stakeDianthus Therapeutics
DNTH
3.6% stake
1,946,667 sh
3.6% stake
Filed 05/14
